Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

The first in-human trials for an artificial lamellar implant demonstrates the device’s potential to treat corneal edema.

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...

A Brighton man has become the first patient at Sussex Eye Hospital to undergo a "pioneering" artificial cornea transplant.

The study was led by Harvard Medical School and Massachusetts Eye and Ear researchers and surgeons. The researchers reported ...

A type of eye injury that caused blindness and was previously believed to be irreversible was cured in human trials using ...

Researchers successfully pulled off the first eye stem cell transplants to help heal cornea damage, and the results speak for ...

A new, cutting-edge transplant procedure to help restore sight loss for patients with a damaged cornea is now being offered ...

Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals ...

Founded by the late Dr. Hudson Silva, the Sri Lanka Eye Donation Society (SLEDS) which is nearing 65 years is the first of its kind in the world to provide corneas completely free of charge to locals ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that ...